UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) January 26, 2006
TEMPUR-PEDIC INTERNATIONAL INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 001-31922 | 33-1022198 | ||
| (State or other jurisdiction | (Commission File No.) | (I.R.S. Employer | ||
| of incorporation) | Identification No.) |
1713 Jaggie Fox Way
Lexington, Kentucky 40511
(Address of principal executive offices) (Zip Code)
(800) 878-8889
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
On January 26, 2006, Tempur-Pedic International Inc. issued a press release to announce its financial results for the fourth quarter and full year ended December 31, 2005, including certain non-GAAP financial results. This press release includes reconciliations of such non-GAAP financial measures to the most directly comparable GAAP financial measures and is furnished herewith as Exhibit 99.1 and incorporated by reference herein.
The information in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
| ITEM 7.01. REGULATION FD DISCLOSURE |
The information furnished under Item 2.02 of this Form 8- K, including Exhibit 99.1 furnished herewith, is hereby incorporated by reference under this Item 7.01 as if fully set forth herein.
Item 9.01. Financial Statements and Exhibits
| (c) | Exhibits |
| Exhibit |
Description | |
| 99.1 | Press Release dated January 26, 2006, titled “Tempur-Pedic International Reports Fourth Quarter and Full Year Earnings.” | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 26, 2006
| Tempur-Pedic International Inc. | ||||
| By: | /s/ Robert B. Trussell, Jr. | |||
| Name: |
Robert B. Trussell, Jr. | |||
| Title: |
ChiefExecutive Officer | |||
EXHIBIT INDEX
| Exhibit |
Description | |
| 99.1 | Press Release dated January 26, 2006, titled “Tempur-Pedic International Reports Fourth Quarter and Full Year Earnings.” | |
4
Exhibit 99.1
| Contact: |
Investor Relations | |
| Tempur-Pedic International Inc. | ||
| 800-805-3635 |
For Immediate Release
TEMPUR-PEDIC INTERNATIONAL REPORTS FOURTH QUARTER AND FULL YEAR EARNINGS
– Pro Forma EPS Up 28% and GAAP EPS Up 30% in Fourth Quarter
– Company to Introduce New Mattresses, Expand R&D and Marketing Programs, and Increase Share Repurchase Program in 2006
LEXINGTON, KY, January 26, 2006 – Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announced net sales and earnings for the fourth quarter and full year ended December 31, 2005. The Company also announced key business initiatives and financial guidance for 2006, a $100.0 million expansion of its share repurchase program and an additional repatriation of foreign earnings.
Fourth Quarter 2005 Financial Summary
| • | Net sales rose 9% to $215.6 million from $198.4 million in the fourth quarter of 2004. Retail channel sales worldwide increased 15%. Sales in the U.S. retail channel grew 7%. Sales in the international retail channel increased 30%. |
| • | Pro forma EPS rose 28% to $0.32 per diluted share in the fourth quarter of 2005 from $0.25 per diluted share in the fourth quarter of 2004. EPS under Generally Accepted Accounting Principles (GAAP) rose 30% to $0.30 per diluted share in the fourth quarter of 2005 from $0.23 per diluted share in the fourth quarter of 2004. |
| • | The Company repurchased more than 6.8 million shares of its common stock at a total cost of $76.0 million during the fourth quarter. The Company’s Board of Directors has authorized a $100.0 million increase in the Company’s share repurchase program. |
| • | The Company completed the repatriation of an additional $40.7 million of foreign earnings, related to the American Jobs Creation Act of 2004, for a total of $155.7 million of foreign earnings repatriated during the year. |
For the fourth quarter of 2005, the Company reported net income under GAAP of $30.4 million compared to $23.9 million in the fourth quarter of 2004, an increase in net income of 27%. Pro forma net income rose 23% to $31.5 million from $25.7 million in the fourth quarter of 2004. GAAP results for the fourth quarter of 2005 include a one-time charge of $0.02 per fully diluted share to recognize the loss on debt extinguishment related to the previously disclosed refinancing of the Company’s senior credit facility, a $0.01 charge for non-cash stock-based compensation expense and a one-time tax benefit of $0.01 per fully diluted share related to a favorable tax ruling. Share repurchases contributed approximately $0.01 to fourth quarter 2005 fully diluted EPS.
For a complete discussion of pro forma adjustments, see the Supplemental Information included later in this press release.
Full-year 2005 Financial Summary
For the full year ended December 31, 2005, net sales totaled $836.7 million, 22% higher than net sales for the year ended December 31, 2004. Retail channel sales worldwide were strong, rising 31%. Reflecting the strong cash flow dynamics of the business, operating cash flows rose 33% to $102.2 million for the full year 2005, up from $77.0 million for 2004. The Company reported full year 2005 GAAP net income of $99.3 million, or $0.97 per diluted share, compared to $75.0 million, or $0.73 per diluted share, for 2004. This represents a 32% increase in GAAP net income and a 33% increase in GAAP net income per diluted share. The Company also reported full year 2005 pro forma net income of $109.0 million, or $1.07 per diluted share, compared to $84.4 million, or $0.82 per diluted share, for 2004. This represents a 29% increase in pro forma net income and a 30% increase in pro forma net income per diluted share.
Chief Executive Officer Robert B. Trussell, Jr. commented, “2005 was a solid year with continued growth in net sales and earnings. We were very pleased to deliver earnings per share at the high end of our expectations, even though sales were less than guidance. Our fourth quarter performance demonstrates Tempur-Pedic’s ability to generate strong earnings in the face of a more challenging sales environment, sharp increases in raw material prices in our industry and increased transportation costs.”
President H. Thomas Bryant noted, “In the fourth quarter, our specialty retail channel was weaker than expected for pillows and mattresses. Additionally, we opened or expanded distribution in several large U.S. accounts later in the quarter than we had originally expected, which impacted the level of sell-through. Lastly, while our international pillow business continues to recover, it was not at the levels we had anticipated for the quarter.
“We have undertaken several initiatives to accelerate U.S. sales growth and otherwise strengthen our business in 2006. We are expanding our retail sales force in both the U.S. and internationally. To continue building brand awareness, we are increasing our marketing investment around the world. In addition, we will selectively expand our distribution in retail accounts in the U.S., Europe and Asia.
“We are also focusing on our commitment to be the leader in innovation and new product development by increasing investment in R&D. Continuing our longstanding commitment to the premium market, next week at the Las Vegas furniture show we will launch two new high-end mattresses, ‘The GrandBed by Tempur-Pedic™’ and ‘The RhapsodyBed by Tempur-Pedic™’, whose queen-size mattresses will retail at $5,499 and $2,399, respectively. In addition, based on an analysis of our U.S. mattress sales and consumer feedback, we have redesigned the Classic model and will launch it next week. We expect this launch to support our effort to accelerate unit volume growth.
“During 2005 we successfully executed our strategy of delivering effective, low cost operations by implementing a number of initiatives to generate productivity improvements and cost reductions throughout our manufacturing and supply chain operations. These initiatives have already provided a significant benefit to our business and we will expand them in 2006.”
Expanded Share Repurchase Program and Amendment to Senior Credit Facility
In connection with the Company’s $80.0 million share repurchase program announced in October 2005, during the fourth quarter of 2005 the Company purchased more than 6.8 million shares of its common stock for a total cost of $76.0 million. Common shares outstanding at December 31, 2005 were 92.4 million, compared to 98.2 million at the end of 2004.
The Company also announced that the Board of Directors has increased the total amount of the Company’s share repurchase program by $100.0 million to $180.0 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price,
financing and regulatory requirements and other market conditions. Repurchases may also be made under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. This share repurchase program may be limited, suspended or terminated at any time without prior notice.
In connection with the expansion of the share repurchase program, the Company intends to amend its existing senior credit facility and has received commitments from its lenders to increase the U.S. revolver component. The Company expects that this amendment will be completed in the next week.
Mr. Trussell commented: “We are very confident in the Company’s future, our superior products and our ability to remain the market leader in the visco-elastic category. We believe the share repurchase program is an attractive vehicle to significantly increase shareholder value over the long term, particularly in light of the strong cash flow generated by the Company’s business model.”
2006 Guidance
The Company issued full-year 2006 guidance for net sales and pro forma diluted net income per share. It currently expects net sales for 2006 to range from $940.0 million to $970.0 million, an increase of 12% to 16% over 2005. It currently expects pro forma diluted earnings per share for 2006 to range from $1.20 to $1.25, which excludes a full year GAAP charge of approximately $0.02 for stock option expense. This guidance reflects an increase of 12% to 17% compared to 2005 pro forma earnings per share of $1.07. The Company’s earnings guidance reflects the Company’s traditional practice of incurring heavier marketing expenditures as a percentage of sales in the first quarter of each year. The Company notes that its guidance for diluted earnings per share does not assume any benefit from a potential reduction in shares outstanding related to future share repurchases. The Company expects full year capital expenditures to be approximately $35.0 million, which includes $15.0 million related to its Albuquerque, New Mexico production facility. The Company also notes that its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company’s control.
Conference Call Information
Tempur-Pedic International will host a live conference call with Chief Executive Officer Robert Trussell, Jr., President H. Thomas Bryant, and Chief Financial Officer Dale Williams to discuss fourth quarter financial results today, January 26, 2006 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). The dial-in number for the conference call is 706-634-0167. The call is also being webcast, and can be accessed at http://www.tempurpedic.com/ir.
For those who cannot listen to the live broadcast, a replay of the call will be available from January 26, 2006 at 8:00 p.m. Eastern Time through February 2, 2006. To listen to the telephone replay, dial 706-645-9291, conference ID #4096405.
An archived webcast will also be available on the Tempur-Pedic International investor relations website at http://www.tempurpedic.com/ir.
Forward-looking Statements
This release contains “forward-looking statements,” within the meaning of federal securities laws, which include information concerning one or more of the Company’s plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including without limitation, initiatives to increase sales, the rollout and market acceptance of new products, initiatives to generate productivity improvements and reduce costs, the Company’s intention to repurchase shares of its common stock from time to time under its share repurchase program and to obtain an amendment to its senior credit facility, and management’s expectations regarding its net sales, pro forma and GAAP net income and capital expenditures for 2006, are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.
There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. These risk factors include general economic and industry conditions and consumer confidence; uncertainties arising from global events; consumer acceptance of the Company’s products; industry competition; the efficiency and effectiveness of the Company’s advertising campaigns and other marketing programs; the Company’s ability to further penetrate the US retail furniture channel, including the timing of opening or expanding within large retail accounts; the Company’s ability to continuously improve its product line, maintain efficient, timely and cost-effective production and delivery of its products, and manage its growth; rising commodity costs; the market price for the Company’s common stock prevailing from time to time; and the nature of other investment opportunities presented to the Company from time to time. Additional information concerning these and other risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission, including without limitation the Company’s annual report on Form 10-K under the headings “Special Note Regarding Forward-Looking Statements” and “Business-Risk Factors”. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements for any reason, including to reflect events or circumstances after the date on which such statements are made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
About the Company
Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes Swedish Mattresses and Neck Pillows™ made from its proprietary TEMPUR® pressure-relieving material: a visco-elastic material that conforms to the body to provide support and help alleviate pressure points. Products are currently sold in 60 countries under the TEMPUR® and Tempur-Pedic® brand names. World headquarters for Tempur-Pedic International is in Lexington, KY.
For more information, visit http://www.tempurpedic.com or call 800-805-3635.
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Statements of Income
(In thousands, except per share amounts)
| Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||||||||||||||||||||
| 2005 |
2004 |
Chg % |
2005 |
2004 |
Chg % |
|||||||||||||||||
| Net sales |
$ | 215,643 | $ | 198,406 | 9 | % | $ | 836,732 | $ | 684,866 | 22 | % | ||||||||||
| Cost of sales |
106,997 | 95,624 | 412,790 | 323,852 | ||||||||||||||||||
| Gross profit |
108,646 | 102,782 | 6 | % | 423,942 | 361,014 | 17 | % | ||||||||||||||
| Selling and marketing expenses |
37,480 | 37,216 | 162,188 | 138,735 | ||||||||||||||||||
| General and administrative expenses |
16,355 | 19,987 | 68,204 | 68,961 | ||||||||||||||||||
| Research and development expenses |
752 | 902 | 2,696 | 2,283 | ||||||||||||||||||
| Operating expense |
54,587 | 58,105 | (6 | )% | 233,088 | 209,979 | 11 | % | ||||||||||||||
| Operating income |
54,059 | 44,677 | 21 | % | 190,854 | 151,035 | 26 | % | ||||||||||||||
| Other income (expense), net: |
||||||||||||||||||||||
| Interest expense, net |
(4,958 | ) | (5,685 | ) | (20,264 | ) | (23,550 | ) | ||||||||||||||
| Loss on extinguishment of debt |
(3,528 | ) | — | (4,245 | ) | (5,381 | ) | |||||||||||||||
| Other income (expense), net |
(40 | ) | 62 | 127 | 83 | |||||||||||||||||
| Total other expense |
(8,526 | ) | (5,623 | ) | (24,382 | ) | (28,848 | ) | ||||||||||||||
| Income before income taxes |
45,533 | 39,054 | 166,472 | 122,187 | ||||||||||||||||||
| Income tax provision |
15,172 | 15,174 | 67,143 | 47,180 | ||||||||||||||||||
| Net income |
$ | 30,361 | $ | 23,880 | 27 | % | $ | 99,329 | $ | 75,007 | 32 | % | ||||||||||
| Earnings per share: |
||||||||||||||||||||||
| Basic |
$ | 0.32 | $ | 0.24 | $ | 1.01 | $ | 0.77 | ||||||||||||||
| Diluted |
$ | 0.30 | $ | 0.23 | $ | 0.97 | $ | 0.73 | ||||||||||||||
| Weighted average shares outstanding: |
||||||||||||||||||||||
| Basic |
95,762 | 97,977 | 98,012 | 97,695 | ||||||||||||||||||
| Diluted |
99,563 | 103,208 | 102,144 | 102,876 | ||||||||||||||||||
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Balance Sheet
(In thousands)
| December 31, 2005 |
December 31, 2004 |
Chg % |
|||||||||
| ASSETS |
|||||||||||
| Current Assets: |
|||||||||||
| Cash and cash equivalents |
$ | 17,855 | $ | 28,368 | |||||||
| Accounts receivable, net |
111,726 | 93,804 | |||||||||
| Inventories |
81,064 | 66,162 | |||||||||
| Prepaid expenses and other current assets |
11,072 | 12,523 | |||||||||
| Income taxes receivable |
19 | 4,136 | |||||||||
| Deferred income taxes |
6,532 | 8,853 | |||||||||
| Total current assets |
228,268 | 213,846 | 7 | % | |||||||
| Property, plant and equipment, net |
193,224 | 138,457 | |||||||||
| Goodwill |
199,962 | 200,810 | |||||||||
| Other intangible assets, net |
73,908 | 76,122 | |||||||||
| Deferred financing and other non-current assets, net |
6,949 | 10,388 | |||||||||
| Total assets |
$ | 702,311 | $ | 639,623 | 10 | % | |||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||||||||||
| Current Liabilities: |
|||||||||||
| Accounts payable |
$ | 33,639 | $ | 34,771 | |||||||
| Accrued expenses and other |
56,570 | 55,600 | |||||||||
| Current portion of long-term debt |
30,770 | 8,758 | |||||||||
| Total current liabilities |
120,979 | 99,129 | 22 | % | |||||||
| Long-term debt |
313,711 | 280,913 | |||||||||
| Deferred income taxes |
40,386 | 43,771 | |||||||||
| Other non-current liabilities |
906 | 2,189 | |||||||||
| Total liabilities |
475,982 | 426,002 | 12 | % | |||||||
| Stockholders’ Equity: Common stock - $.01 par value; 300,000 shares authorized; 99,215 and 92,448 shares issued and outstanding, respectively in 2005; and 98,194 shares issued and outstanding in 2004 |
992 | 982 | |||||||||
| Treasury stock, at cost; 6,766 shares in 2005 |
(75,218 | ) | — | ||||||||
| Additional paid in capital |
255,369 | 253,134 | |||||||||
| Deferred stock compensation - net of amortization of $12,313 and $9,429, respectively |
(2,196 | ) | (5,079 | ) | |||||||
| Retained earnings (deficit) |
46,245 | (52,623 | ) | ||||||||
| Accumulated other comprehensive income |
1,137 | 17,207 | |||||||||
| Total stockholders’ equity |
226,329 | 213,621 | 6 | % | |||||||
| Total liabilities and stockholders’ equity |
$ | 702,311 | $ | 639,623 | 10 | % | |||||
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Consolidated Statement of Cash Flows
(In thousands)
| Twelve Months Ended December 31, |
|||||||||||
| 2005 |
2004 |
Chg % |
|||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: |
|||||||||||
| Net income |
$ | 99,329 | $ | 75,007 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||||||
| Depreciation and amortization |
24,999 | 23,312 | |||||||||
| Amortization of deferred financing costs |
2,153 | 3,488 | |||||||||
| Loss on extinguishment of debt |
4,245 | — | |||||||||
| Stock-based compensation amortization |
2,883 | 5,207 | |||||||||
| Allowance for doubtful accounts |
2,666 | 3,681 | |||||||||
| Deferred income taxes |
4,424 | 4,685 | |||||||||
| Foreign currency adjustments |
1,022 | 866 | |||||||||
| Loss on sale of equipment and other |
754 | 434 | |||||||||
| Changes in operating assets and liabilities: |
|||||||||||
| Accounts receivable |
(27,273 | ) | (32,996 | ) | |||||||
| Inventories |
(18,448 | ) | (6,292 | ) | |||||||
| Prepaid expenses and other current assets |
258 | (6,520 | ) | ||||||||
| Accounts payable |
1,653 | 6,667 | |||||||||
| Accrued expenses and other |
(1,539 | ) | 1,316 | ||||||||
| Income taxes |
5,123 | (1,889 | ) | ||||||||
| Net cash provided by operating activities |
102,249 | 76,966 | 33 | % | |||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: |
|||||||||||
| Payments for trademarks and other intellectual property |
(2,014 | ) | (342 | ) | |||||||
| Purchases of property, plant and equipment |
(84,881 | ) | (38,419 | ) | |||||||
| Proceeds from sale of equipment |
311 | 410 | |||||||||
| Net cash used by investing activities |
(86,584 | ) | (38,351 | ) | 126 | % | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: |
|||||||||||
| Proceeds from long-term Revolving Credit Facility |
368,500 | 50,512 | |||||||||
| Repayments of long-term Revolving Credit Facility |
(302,500 | ) | (48,670 | ) | |||||||
| Proceeds from issuance of long-term debt |
109,858 | — | |||||||||
| Repayments of long-term debt |
(173,688 | ) | (37,688 | ) | |||||||
| Repayments of Senior Subordinated Notes |
— | (52,500 | ) | ||||||||
| Proceeds from issuance of Industrial Revenue Bonds |
53,925 | — | |||||||||
| Cash held in trust for repayment of Senior Subordinated Notes |
— | 60,243 | |||||||||
| Common stock issued, including reissuances of treasury shares |
2,551 | 1,847 | |||||||||
| Treasury shares repurchased |
(76,000 | ) | — | ||||||||
| Payments of deferred financing costs |
(2,601 | ) | (2,251 | ) | |||||||
| Net cash used by financing activities |
(19,955 | ) | (28,507 | ) | (30 | )% | |||||
| NET EFFECT OF EXCHANGE RATE CHANGES ON CASH |
(6,223 | ) | 4,030 | ||||||||
| Increase (decrease) in cash and cash equivalents |
(10,513 | ) | 14,138 | ||||||||
| CASH AND CASH EQUIVALENTS, beginning of period |
28,368 | 14,230 | |||||||||
| CASH AND CASH EQUIVALENTS, end of period |
$ | 17,855 | $ | 28,368 | (37 | )% | |||||
Supplemental Information
Pro Forma Net Income and Other Financial Data
To further provide investors useful information, pro forma net income is presented and represents the Company’s GAAP net income before income tax expense on repatriation of foreign dividend, income tax benefit from a favorable state tax ruling, non-cash stock-based compensation expense, and loss on debt extinguishment for the three and twelve months ended December 31, 2005.
The Company believes that excluding the above items provide a measure that is more representative of ongoing costs and therefore more comparable to the Company’s historical operations. The following is a reconciliation of GAAP net income to pro forma net income and per share amounts:
TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Reconciliation of GAAP Net Income to Pro Forma Net Income,
and Other Financial Data
(In thousands, except per share data)
| Three Months Ended December 31, |
Twelve Months Ended December 31, | |||||||||||||
| 2005 |
2004 |
2005 |
2004 | |||||||||||
| GAAP net income |
$ | 30,361 | $ | 23,880 | $ | 99,329 | $ | 75,007 | ||||||
| Income tax provision on repatriation dividend |
80 | — | 6,571 | — | ||||||||||
| Income tax benefit on favorable state tax ruling |
(1,588 | ) | — | (1,588 | ) | — | ||||||||
| Non-cash stock-based compensation expense |
462 | 915 | 2,445 | 5,171 | ||||||||||
| Secondary public offering expenses |
— | 939 | — | 939 | ||||||||||
| Loss on extinguishment of debt, net of tax |
2,212 | — | 2,212 | 3,309 | ||||||||||
| Pro forma net income |
$ | 31,527 | $ | 25,734 | $ | 108,969 | $ | 84,426 | ||||||
| GAAP net income per share, diluted |
$ | 0.30 | 0.23 | 0.97 | 0.73 | |||||||||
| Income tax provision on repatriation dividend |
— | — | 0.07 | — | ||||||||||
| Income tax benefit on favorable state tax ruling |
(0.01 | ) | — | (0.01 | ) | — | ||||||||
| Non-cash stock-based compensation expense |
0.01 | 0.01 | 0.02 | 0.05 | ||||||||||
| Secondary public offering expense |
— | 0.01 | — | 0.01 | ||||||||||
| Loss on extinguishment of debt, net of tax |
0.02 | — | 0.02 | 0.03 | ||||||||||
| Pro forma net income per share, diluted |
$ | 0.32 | 0.25 | 1.07 | 0.82 | |||||||||
| Other financial data |
||||||||||||||
| Depreciation and Amortization |
$ | 6,755 | $ | 7,325 | $ | 27,882 | $ | 28,519 | ||||||
| Net debt |
$ | 326,626 | $ | 261,303 | $ | 326,626 | $ | 261,303 | ||||||
Summary of Channel Sales
The Company generates sales through four distribution channels: retail, direct, healthcare and third party. The retail channel sells to furniture, specialty and department stores globally. The direct channel sells directly to consumers. The healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers. The third party channel sells to distributors in countries where Tempur-Pedic International does not operate its own distribution company.
The following table highlights net sales information, by channel and by segment, for the fourth quarter of 2005 compared to 2004:
| ($ in thousands) | ||||||||||||||||||
| CONSOLIDATED Three Months Ended December 31, |
DOMESTIC Three Months Ended December 31, |
INTERNATIONAL Three Months Ended December 31, | ||||||||||||||||
| 2005 |
2004 |
2005 |
2004 |
2005 |
2004 | |||||||||||||
| By Sales Channel |
||||||||||||||||||
| Retail |
$ | 166,580 | $ | 145,321 | $ | 104,838 | $ | 97,826 | $ | 61,742 | $ | 47,495 | ||||||
| Direct |
24,768 | 27,120 | 20,882 | 22,446 | 3,886 | 4,674 | ||||||||||||
| Healthcare |
11,844 | 12,869 | 2,654 | 3,231 | 9,190 | 9,638 | ||||||||||||
| Third Party |
12,451 | 13,096 | 3,605 | 2,959 | 8,846 | 10,137 | ||||||||||||
| Total |
$ | 215,643 | $ | 198,406 | $ | 131,979 | $ | 126,462 | $ | 83,664 | $ | 71,944 | ||||||
| Summary of Product Sales | ||||||||||||||||||
| A summary of net sales by product is reported below: |
||||||||||||||||||
| ($ in thousands) |
||||||||||||||||||
| CONSOLIDATED Three Months Ended December 31, |
DOMESTIC Three Months Ended December 31, |
INTERNATIONAL Three Months Ended December 31, | ||||||||||||||||
| 2005 |
2004 |
2005 |
2004 |
2005 |
2004 | |||||||||||||
| Net Sales |
||||||||||||||||||
| Mattresses |
$ | 142,418 | $ | 127,176 | $ | 93,466 | $ | 87,488 | $ | 48,952 | $ | 39,688 | ||||||
| Pillows |
33,367 | 37,762 | 15,222 | 17,487 | 18,145 | 20,275 | ||||||||||||
| Other |
39,858 | 33,468 | 23,291 | 21,487 | 16,567 | 11,981 | ||||||||||||
| Total |
$ | 215,643 | $ | 198,406 | $ | 131,979 | $ | 126,462 | $ | 83,664 | $ | 71,944 | ||||||
| Units Sold(1) |
||||||||||||||||||
| Mattresses |
176,221 | 154,908 | 89,689 | 90,072 | 86,532 | 64,836 | ||||||||||||
| Pillows |
669,529 | 784,478 | 313,004 | 366,671 | 356,525 | 417,807 | ||||||||||||
| (1) | Units sold represent net sales after consideration of returned mattresses and pillows and excludes units shipped to fulfill warranty claims and promotional activities. |
The following table highlights net sales information, by channel and by segment, for the full year of 2005 compared to 2004:
| ($ in thousands) | ||||||||||||||||||
| CONSOLIDATED Twelve Months Ended December 31, |
DOMESTIC Twelve Months Ended December 31, |
INTERNATIONAL Twelve Months Ended December 31, | ||||||||||||||||
| 2005 |
2004 |
2005 |
2004 |
2005 |
2004 | |||||||||||||
| By Sales Channel |
||||||||||||||||||
| Retail |
$ | 638,977 | $ | 489,480 | $ | 426,069 | $ | 327,081 | $ | 212,908 | $ | 162,399 | ||||||
| Direct |
103,197 | 99,687 | 88,555 | 84,147 | 14,642 | 15,540 | ||||||||||||
| Healthcare |
45,949 | 46,555 | 10,998 | 11,446 | 34,951 | 35,109 | ||||||||||||
| Third Party |
48,609 | 49,144 | 10,664 | 8,044 | 37,945 | 41,100 | ||||||||||||
| Total |
$ | 836,732 | $ | 684,866 | $ | 536,286 | $ | 430,718 | $ | 300,446 | $ | 254,148 | ||||||
| Summary of Product Sales | ||||||||||||||||||
| A summary of net sales by product is reported below: |
||||||||||||||||||
| ($ in thousands) |
||||||||||||||||||
| CONSOLIDATED Twelve Months Ended December 31, |
DOMESTIC Twelve Months Ended December 31, |
INTERNATIONAL Twelve Months Ended December 31, | ||||||||||||||||
| 2005 |
2004 |
2005 |
2004 |
2005 |
2004 | |||||||||||||
| Net Sales |
||||||||||||||||||
| Mattresses |
$ | 566,460 | $ | 433,285 | $ | 391,942 | $ | 302,501 | $ | 174,518 | $ | 130,784 | ||||||
| Pillows |
126,227 | 138,044 | 54,014 | 54,321 | 72,213 | 83,723 | ||||||||||||
| Other |
144,045 | 113,537 | 90,330 | 73,896 | 53,715 | 39,641 | ||||||||||||
| Total |
$ | 836,732 | $ | 684,866 | $ | 536,286 | $ | 430,718 | $ | 300,446 | $ | 254,148 | ||||||
| Units Sold(1) |
||||||||||||||||||
| Mattresses |
685,316 | 547,705 | 383,663 | 323,444 | 301,653 | 224,261 | ||||||||||||
| Pillows |
2,535,981 | 2,896,786 | 1,100,725 | 1,117,640 | 1,435,256 | 1,779,146 | ||||||||||||
| (1) | Units sold represent net sales after consideration of returned mattresses and pillows and excludes units shipped to fulfill warranty claims and promotional activities. |